Linamar (TSE:LNR – Get Free Report) had its target price reduced by stock analysts at TD Securities from C$92.00 to C$89.00 in a research note issued to investors on Monday, BayStreet.CA reports. The firm currently has a “buy” rating on the stock. TD Securities’ price objective points to a potential upside of 41.65% from the stock’s previous close.
A number of other equities analysts have also recently commented on the company. CIBC decreased their target price on Linamar from C$92.00 to C$88.00 in a report on Friday, August 9th. BMO Capital Markets cut their price target on Linamar from C$90.00 to C$80.00 in a research note on Friday, August 9th. One investment analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of C$84.20.
View Our Latest Stock Report on LNR
Linamar Price Performance
Linamar (TSE:LNR – Get Free Report) last announced its earnings results on Thursday, August 8th. The company reported C$3.06 EPS for the quarter, topping analysts’ consensus estimates of C$2.70 by C$0.36. Linamar had a return on equity of 11.31% and a net margin of 5.77%. The company had revenue of C$2.85 billion for the quarter, compared to analysts’ expectations of C$2.92 billion. Sell-side analysts anticipate that Linamar will post 11.4332724 earnings per share for the current year.
Linamar Company Profile
Linamar Corporation, together with its subsidiaries, produces engineered products in Canada, Europe, the Asia Pacific, and rest of North America. It operates through two segments, Mobility and Industrial. The Mobility segment focuses on light metal casting, forging, machining, and assembly for electrified and powered vehicle markets.
Further Reading
- Five stocks we like better than Linamar
- Are Penny Stocks a Good Fit for Your Portfolio?
- Why Lennar Stock Could Be the Best Play in the Housing Market
- Retail Stocks Investing, Explained
- 2 Energy Stocks Fueling the AI Datacenter Boom
- Why is the Ex-Dividend Date Significant to Investors?
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for Linamar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Linamar and related companies with MarketBeat.com's FREE daily email newsletter.